NCT06614218Completed
MIMS® Retrospective Chart Review
Minimally Invasive Micro Sclerostomy (MIMS®) Retrospective Chart Review
Source: ClinicalTrials.gov · Last updated 15 Oct 2026
Brief summary (registry, in English)
This is a post-market clinical follow-up, retrospective chart review of MIMS® surgical procedures conducted during time period between Sep 2023 and April 2025.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 34 (actual)
- First submitted
- 24 Sept 2024
- Start date
- 27 Sept 2023
- Primary completion date
- 25 Apr 2024
- Lead sponsor
- Sanoculis Ltd
- Diseases
- Glaucoma
- NCT number
- NCT06614218
What you commit to
- Study type: Observational
- Participants enrolled: 34
- From 27 Sept 2023 to the primary completion date, 25 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Eye treated with MIMS® Device as a standalone procedure
- MIMS® surgery was performed between 27 Sep 2023 and 30 April 2024
Age in the registry: 40 years to 85 years · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| S. Malayan Eye Center Coordinator of this site? Confirm its status | Yerevan | Armenia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.